Mutations of genes associated with thromboses in ischemlc stroke in patients with primary antiphospholipid syndrome

Terapevticheskii Arkhiv

Volumn 77, Issue 10, 2005, Pages 49-53

  Kalashnikova, L A ^a   Dobrynina, L A ^a   Patrusheva, N L ^a   Kovalenko, T F ^a   Patrushev, L I ^a   Aleksandrova, E N ^a   Berkovsky, A L ^a   Sergeeva, E V ^a   Nasonov, E L ^a  

^a NONE

Author keywords

Antiphospholipid syndrome; Cerebrovascular disease; Factor V Leiden mutation; Ischemic stroke; Methylenetetrahydrofolate reductase (C677T) mutation; Prothrombin mutation (G20210A)

Indexed keywords

BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTHROMBIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; FEMALE; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MUTATION; THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CEREBROVASCULAR DISORDERS; FACTOR V; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PROTHROMBIN; THROMBOSIS;

EID: 28144451211     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Harris E. N., Baguley E., Asherson R. A. "The antiphospholipid syndrome", definition and clinical features. Clin. Exp. Rheum. 1988; 6: A46.
2. Rand J. H. The antiphospholipid syndrome. Annu. Rev. Med. 2003; 54: 409-424.
3. Asherson R. A. A "Primary" antiphospholipid syndrome. J. Rheumatol. 1988; 15: 1742-1746.
4. deGroot P. G., Horbach D. A., Derksen R. Protein C and other cofactors involved in the binding of phospholipid antibodies: relation to the pathogenesis of thrombosis. Lupus 1996; 5: 488-493.
5. Roubey R. Immunology of the antiphospholipid antibody syndrome. Arthr. and Rheum. 1996; 39: 1444-1454.
6. Ford P., Brunet D., Lillicrap D. et al. Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies. Stroke 1990; 21: 66-71.
7. Lousa M., Sastre J., Cancelas J. et al. Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family. Stroke 1994; 25: 1071-1074.
8. Wilson W. A., Gharavi A. E. Genetic risk factors for aPL syndrome. Lupus 1996; 5: 398-403.
9. Hademenos G., Alberts M., Awad I. et al. Advances in the genetics of cerebrovascular disease and stroke. Neurology 2001; 56: 997-1008.
10. Chopra N., Koren S., Greer W. L. et al. Factor V Leiden, prothrombin gene mutation and thrombosis risk in patients with antiphospholipid antibodies. J. Rheumatol. 2002; 29: 1683-1688.
11. Pablos J. L., Caliz R. A., Carreira P. E. et al. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. J. Rheumatol. 1999; 26: 588-590.
12. Picillo U., De Lucia D., Palatiello E. et al. Association of primary antiphospholipid syndrome with inherited activated protein C resistance. J. Rheumatol. 1998; 25: 1232-1234.
13. Bertina R. M., Koeleman B. P. C., Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
14. Maat M. P. M., Kluft C., Jespersen J., Gram J. World distribution of factor V Leiden mutation. Lancet 1996; 347: 58.
15. Poort S. R., Rosendaal F. R., Reitsma P. H., Bertina R. M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
16. Guba S. C., Fonseca V., Fink L. M. Hyperhomocyteinemia and thrombosis. Semin. Thromb. Haemost. 1999; 25: 291-309.
17. Madonna P., de Stefano V., Coppola A. et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002; 33 (1): 51-56.
18. Lopaciuk S., Bykowska K., Kwiecinski H. et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin. Appl. Thromb. Hemost. 2001; 7 (4): 346-350.
19. Patrushev L. I., Zykova E. S., Kayushin A. L. et al. New DNA diagnostic system for detection of Factor V Leiden. Thromb. Res. 1998; 92: 251-259.
20. Brandt J. T., Triplett D. A., Alving B. et al. Criteria for the diagnosis of lupus anticoagulan: an update. Thromb. Haemost. 1995; 74: 1185-1190.
21. Wilson W. A., Gharavi A. E., Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthr. and Rheum. 1999; 42: 1309-1311.
22. De Stefano V., Chiusolo P., Paciaroni K., Leone G. Epidemiology of factor V Leiden: Clinical implications. Semin. Thromb. Hemost. 1998; 24: 367-379.
23. Fijnheer R., Horbach D. A., Donders R. C. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb. Haemost. 1996; 76: 514-517.
24. Besnier R., Frances C., Ankri A. et al. Factor V Leiden mutation in Sneddon syndrome. Lupus 2003; 12 (5): 406-408.
25. Zivelin A., Gitel S., Griffin J. H. et al. Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C. Blood 1999; 94: 895-901.
26. Deschiens M. A., Canard J., Horellou M. H. et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996; 27: 1724-1730.
27. Gln mutation in patients with antiphospholipid antibodies. Lupus 1996; 5: 303-306.
28. Catto A. J., Carter A. M., Ireland H. et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 783-785.
29. Catto A. J., Carter A. M., Grant P. J. Factor V Leiden mutation and completed stroke. Stroke 1996; 27: 573.
30. Ridker P. M., Hennekens C. H., Lindpaintner K. et al. Mutation in the gene coding for coagulation factor V and the risk of myocadial infarction, stroke, and venous thrombosis in apparently healthy men. N. Engl. J. Med. 1995; 332: 912-917.
31. Vargas M., Soto I., Pinto C. R. et al. The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disese. Blood Coagul. Fibrinolys. 1999; 10: 39-41.
32. Kenet G., Sadetzki S., Murad H. et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 31: 1283-1288.
33. Gardner J. Factor V Leiden with deep venous thrombosis. Clin. Lab. Sci. 2003; 16: 6-9.